Jump to Navigation

Facebook Connect

User login

Donald S. Fredrickson Conference 2018

Register for the Conference

See the Agenda Here

See expert analysis of unique cases!

Register to learn from your peers and their experiences handling unusual cases.

Conference Date: Sunday, April 29, 2018 (in conjunction with Scientific Sessions)

Time: 11:30-3:00pm Pacific

Location: JW Marriott Las Vegas

Registration Fee: $100 for practicing HCPs. $50 for fellows-in-training or residents. Those registered for National Lipid Association’s Scientific Sessions (register here) will receive a discount of $50. 

Course Chair: W. Virgil Brown, MD, FNLA


W. Virgil Brown
W. Virgil Brown, MD, FNLA
Course Chair

The Donald S. Fredrickson Conference on Familial Lipoprotein Disorders will provide a stimulating environment and stage for clinicians to share and discuss case reports of unusual disorders of lipoprotein metabolism. Six cases will be presented, with each case followed by an expert-led discussion of the case. Attendees will leave with a better understanding of gene variants related to lipoprotein abnormalities, the advantages of genetic analysis and testing, and therapeutic targets and experimental techniques in development for genetic manipulation of inherited lipid disorders, with the ultimate goal of increasing the ability of clinicians to more effectively treat blood lipoprotein disorders. 

Register for the Conference


Target Audience: Practicing clinicians, clinical researchers, basic scientists, and other healthcare professionals with an interest in lipid disorders.

Learning Objectives:

Upon completion of the conference, participants should be able to:

  • Discuss the value of genetic analysis and pertinent family history in unusual cases
  • Describe approaches to evaluating rare genetic disorders of lipoprotein metabolism
  • Discuss emerging therapeutic targets and experimental techniques in development for genetic manipulation of inherited lipid disorders
  • Apply insight from human population genetics studies to identify novel therapeutic targets for atherosclerotic cardiovascular disease
  • Analyze genetic information through case studies to improve treatment and prevention of cardiovascular disease

This conference is not certified for CME/CE credit.

No votes yet
Publish Date: 
Tuesday, February 20, 2018 - 13:00

by Dr. Radut.